Sensorion to Present at 60th Inner Ear Biology Workshop

Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, will participate in the 60th Inner Ear Biology Workshop. The event takes place from September 13-16, 2025, in Tübingen, Germany. Géraldine Honnet, M.D., Chief Medical Officer at Sensorion, will deliver a presentation on September 13, 2025, focusing on "SENS-501 Gene Therapy in Young Children with Severe to Profound Hearing Loss Due to Otoferlin Mutations."

Furthermore, Anne-Gabrielle Harrus, Ph.D., will present a poster on "Safety and Efficacy of GJB2-GT," discussing a gene therapy candidate for non-syndromic deafness, scheduled for September 15, 2025. The poster will be accessible on Sensorion’s website after its presentation.